Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06013722 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Strategy for Unstable Coronary Plaque in Patients Presenting to Emergency Department for Chest Pain Suspected of Coronary Artery Disease

Study acronym: SPECTRE
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv13
  2. Notable Primary completion moved earlier from Nov 2026 to Jul 24, 2025
    • Study completion moved earlier from Mar 2028 to Nov 24, 2027
    v12
  3. Notable Enrollment reduced: 250 → 22 participants
    • Trial status changed: Recruiting → Active, Not Recruiting
    • Site details revised
    v11
  4. Minor 3 versions Re-verified since Nov 19, 2025, no change to tracked fieldsv8-v10
  5. Minor Study completion date: Mar 2027 to Mar 2028
    • Site contact updated
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Minor 2 versions Re-verified since Jul 29, 2024, no change to tracked fieldsv5-v6
  2. Minor Eligibility criteria shortened, about 5 wordsv4
  3. Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Aug 2026 to Nov 2026
    • Study completion date: Dec 2027 to Mar 2027
    • Start date changed from estimate of Dec 2023 to Mar 18, 2024
    • Site details revised
  4. Notable Primary endpoints: 3 to 7v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Primary prevention of coronary disease and especially its major complication, inaugural myocardial infarction, is based on any prodromal symptoms identification and on risk profile establishment. About 50% of myocardial infarctions are caused by an unstable non-stenosing plaque, asymptomatic before the event since without significant reduction in coronary flow, particularly during a stress test or during stress imaging. Study purpose is to set up, in medical emergency department, check-up unit and cardiology department, a primary prevention strategy articulated around a routine examination: calcium scoring. The latter makes it possible to categorize patients according to their risk of generating atheromatous plaques and to classify them into several risk levels (groups) according to their score: low (\<40th percentile), intermediate (between the 40th percentile and the 65th percentile: group III) or high risk (\>65th percentile, group IV). 18F-Na PET scan can mark unstable coronary plaques. For the intermediate risk population who would demonstrate within 6 to 18 months after first calcium score either an increase of percentile of more than 20% or an increase above 20 points of the calcium score and for high risk population, 18F-Na PET scan will be recommended and repeated 6 months later. Secondary prevention treatment will then be administered in the event of an abnormal examination.
Trial Details
NCT Number NCT06013722
Lead Sponsor Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Collaborators: Monaco Scientific center
Conditions
(from sponsor)
Atherosclerosis
Related terms Acute Coronary Syndrome, Atherosclerosis, Plaque, Atherosclerotic
Enrollment 22 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov